Epidemiology and prevention of skin and soft tissue infections

Cutis

Volumn 73, Issue 5 SUPPL., 2004, Pages 3-7

  Elston, Dirk M ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; LIDOCAINE; PENICILLIN G; TRICLOSAN;

CLINICAL FEATURE; CONFERENCE PAPER; DRUG HYPERSENSITIVITY; ENTEROCOCCUS; ERYSIPELAS; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; LEG; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

HUMANS; PSEUDOMONAS INFECTIONS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 2642547938     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Saiman L, Jakob K, Holmes KW, et al. Molecular epidemiology of staphylococcal scalded skin syndrome in premature infants. Pediatr Infect Dis J. 1998;17:329-334.
2. Boutoille D, Leautez S, Maulaz D, et al. Skin and osteo-articular bacterial infections of the diabetic foot, treatment [in French]. Presse Med. 2000;29:396-400.
3. Huether MJ, Griego RD, Brodland DG, et al. Clindamycin for intraincisional antibiotic prophylaxis in dermatologic surgery. Arch Dermatol. 2002;138:1145-1148.
4. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. MMWR. 2003;52:88.
5. Manfredi R, Calza L, Chiodo F. Epidemiology and microbiology of cellulitis and bacterial soft tissue infection during HIV disease: a 10-year survey. J Cutan Pathol. 2002;29:168-172.
6. Blanc DS, Pittet D, Ruef C, et al. Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med Wkly. 2002;132:223-229.
7. Simor AE, Ofner-Agostini M, Bryce E, et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ. 2001;165:21-26.
8. Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol. 1992;13:725-737.
9. Zafar AB, Butler RC, Reese DJ, et al. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control. 1995;23:200-208.
10. Marie-Cardine A, Mallet E, Billiemaz K, et al. Severe cutaneous Streptococcus pyogenes infections in the child: results of a multi-center survey [in French]. Arch Pediatr. 2001;8:1325-1332.
11. Passaro DJ, Smitht DS, Hett EC, et al. Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99. Epidemiol Infect. 2002;129:471-478.
12. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis. 2003;3:191-200.
13. Kohler W. Epidemiology and pathogenesis of streptococcal infection [in German]. Immun Infekt. 1992;20:92-98.
14. Carapetis J, Gardiner D, Currie B, et al. Multiple strains of Streptococcus pyogenes in skin sores of aboriginal Australians. J Clin Microbiol. 1995;33:1471-1472.
15. Hansmann Y. What data is needed today to deal with erysipelas? [in French]. Ann Dermatol Venereol. 2001;128:419-428.
16. Dupuy A. Descriptive epidemiology and knowledge of erysipelas risk factors [in French]. Ann Dermatol Venereol. 2001;128:312-316.
17. Crickx B. Erysipelas: evolution under treatment, complications [in French]. Ann Dermatol Venereol. 2001;128:358-362.
18. Becq-Giraudon B. Primary and secondary prevention for erysipelas [in French]. Ann Dermatol Venereol. 2001;128:368-375.
19. Allard P, Stucker M, von Kobyletzki G, et al. Cyclical intravenous antibiosis as an effective therapy concept in chronic recurrent erysipelas [in German]. Hautarzt. 1999;50:34-38.
20. Sylvetsky N, Raveh D, Schlesinger Y, et al. Bacteremia due to beta-hemolytic streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med. 2002;112:622-626.
21. Kwak EJ, McClure JA, McGeer A, et al. Exploring the pathogenesis of necrotizing fasciitis due to Streptococcus pneumoniae. Scand J Infect Dis. 2002;34:639-644.
22. Mulla ZD. Invasive group A streptococcal disease and intensive care unit admissions. Intensive Care Med. 2002;28:1822-1824.
23. Patterson JE, Sweeney AH, Simms M, et al. An analysis of 110 serious enterococcal infections, epidemiology, antibiotic susceptibility, and outcome. Medicine. 1995;74:191-200.
24. Harris A, Torres-Viera C, Venkataraman L, et al. Epidemiology and clinical outcomes of patients with multi-resistant Pseudomonas aeruginosa. Clin Infect Dis. 1999;28:1128-1133.
25. Paraskaki I, Lebessi E, Legakis NJ. Epidemiology of community-acquired Pseudomonas aeruginosa infections in children. Eur J Clin Microbiol Infect Dis. 1996;15:782-786.
26. Fisher RG, Benjamin DK. Facial cellulitis in childhood: a changing spectrum. South Med J. 2002;95:672-674.